Intensity Therapeutics, Inc. (INTS)

Intensity Therapeutics Statistics

Total Valuation

INTS has a market cap or net worth of $7.69 million. The enterprise value is $7.25 million.

Market Cap	7.69M
Enterprise Value	7.25M

Important Dates

The next estimated earnings date is Monday, August 11, 2025, after market close.

Earnings Date	Aug 11, 2025
Ex-Dividend Date	n/a

Share Statistics

INTS has 25.07 million shares outstanding. The number of shares has increased by 27.54% in one year.

Current Share Class	25.07M
Shares Outstanding	25.07M
Shares Change (YoY)	+27.54%
Shares Change (QoQ)	+5.36%
Owned by Insiders (%)	14.05%
Owned by Institutions (%)	10.49%
Float	18.84M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	14.67
P/TBV Ratio	24.10
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.63, with a Debt / Equity ratio of 0.39.

Current Ratio	0.63
Quick Ratio	0.35
Debt / Equity	0.39
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -298.57% and return on invested capital (ROIC) is -184.12%.

Return on Equity (ROE)	-298.57%
Return on Assets (ROA)	-123.09%
Return on Invested Capital (ROIC)	-184.12%
Return on Capital Employed (ROCE)	-3,494.50%
Revenue Per Employee	n/a
Profits Per Employee	-$2.14M
Employee Count	7
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -93.26% in the last 52 weeks. The beta is 3.80, so INTS's price volatility has been higher than the market average.

Beta (5Y)	3.80
52-Week Price Change	-93.26%
50-Day Moving Average	0.35
200-Day Moving Average	1.75
Relative Strength Index (RSI)	41.88
Average Volume (20 Days)	5,482,593

Short Selling Information

The latest short interest is 387,444, so 1.55% of the outstanding shares have been sold short.

Short Interest	387,444
Short Previous Month	412,820
Short % of Shares Out	1.55%
Short % of Float	2.06%
Short Ratio (days to cover)	0.12

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-15.24M
Pretax Income	-15.07M
Net Income	-15.01M
EBITDA	n/a
EBIT	-15.24M
Earnings Per Share (EPS)	-$1.05

Balance Sheet

The company has $929,000 in cash and $131,000 in debt, giving a net cash position of $798,000 or $0.03 per share.

Cash & Cash Equivalents	929,000
Total Debt	131,000
Net Cash	798,000
Net Cash Per Share	$0.03
Equity (Book Value)	334,000
Book Value Per Share	0.02
Working Capital	-978,000

Cash Flow

Operating Cash Flow	-12.84M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

INTS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-27.54%
Shareholder Yield	-27.54%
Earnings Yield	-186.52%
FCF Yield	n/a

Analyst Forecast

The average price target for INTS is $6.75, which is 2,099.41% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$6.75
Price Target Difference	2,099.41%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1